Prokineticin Receptor 2 Antikörper (C-Term)

Produktnummer ABIN4889446

Produktdetails anti-Prokineticin Receptor 2 Antikörper

Target: Prokineticin Receptor 2 (PROKR2)

Bindungsspezifität: C-Term

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Prokineticin Receptor 2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))

Spezifität: Reacts with mouse PK-R2

Kreuzreaktivität: Maus

Kreuzreaktivität (Details): Predicted to cross reacts with PK-R2 and PK-R1 from mouse, rat, human and bovin.

Aufreinigung: Purified (protein A)

Immunogen: Synthetic peptide derived from Cter domain of mouse PK-R2

Anwendungsinformationen

Applikationshinweise:

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IF(1:501:500) WB(1:500 - 1:2000)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Must be reconstituted in distilled water.

Konzentration: 1 mg/mL

Buffer: Tris 0,1M, glycine 0,1M, sucrose 2 %

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.

Haltbarkeit: 24 months

Details zu Prokineticin Receptor 2

Target: Prokineticin Receptor 2 (PROKR2)

Andere Bezeichnung: Prokineticin Receptor 2 (PK-R2) (PROKR2 Produkte)

Synonyme: GPR73L1 antikoerper, GPR73b antikoerper, GPRg2 antikoerper, HH3 antikoerper, KAL3 antikoerper, PKR2 antikoerper, dJ680N4.3 antikoerper, Gpr73l1 antikoerper, B830005M06Rik antikoerper, EG-VEGRF2 antikoerper, Gpcr73l1 antikoerper, prokineticin receptor 2 antikoerper, prokineticin receptor 1 antikoerper, PROKR2 antikoerper, Prokr2 antikoerper, PROKR1 antikoerper

UniProt: Q8K458

Pathways: Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma